Imatinib and the dawn of precision cancer therapy
Nature Medicine – Brian J. Druker describes how his research on imatinib validated protein kinases as therapeutic targets for cancer and led to a life-saving treatment for leukemia.
Nature Medicine – Brian J. Druker describes how his research on imatinib validated protein kinases as therapeutic targets for cancer and led to a life-saving treatment for leukemia.
Nature Reviews Biodiversity – The highly pathogenic avian influenza H5N1 is an emerging and unexpected threat to many wild animal species, which has implications for…
Nature Mental Health – In this study, the authors report that maternal plasma biomarkers of acetaminophen exposure during pregnancy were associated with an increased risk…
THURSDAY, Feb. 13, 2025 (HealthDay News) — You may be less likely to develop an especially lethal form of colon cancer if you’re a longtime…
Nature Medicine – In a randomized controlled trial in individuals with persistent atrial fibrillation, an individualized ablation procedure, in which areas with abnormal electrophysiological…
Advancements in comprehending myelodysplastic neoplasms (MDS) have unfolded significantly in recent years, elucidating a myriad of cellular and molecular underpinnings integral to disease progression…
Nature Reviews Cancer – In this Roadmap, Boire et al. consider the immediate causes of mortality in patients with cancer, a topic not often considered…
Mool mantraIk Onkaar(There is one God)Sat Naam(Whose name is Truth)Kartaa Purakh(Is the creator)Nirbh-a-o Nirvair(Has no fear, Has no hate)Akaal Moorat(Is om…
Maternal platelet-activating antiβplatelet factor 4 antibodies led to cerebral venous sinus thrombosis, thrombocytopenia, hyperfibrinolysis, and cerebral bleeding in a neonate.
Scientific Reports – New insights of cultural cannibalism amongst Magdalenian groups at Maszycka Cave, Poland
Shankar Siva: TFS at 1 year is approximately 90% with SABR / cancer, Daniel Heng, OncoDaily, Oncology, SABR, Shankar Siva